Targeting the dual miRNA/BMP2 network: LncRNA H19-mediated temozolomide resistance unveils novel therapeutic strategies in glioblastoma Authors Qiudan Chen Qingyu Zhou (ORCID: https://orcid.org/0000-0002-4389-1582) Shihao Zhuang (ORCID: https://orcid.org/0000-0002-8958-9047) Wei-Feng Wang (ORCID: https://orcid.org/0000-0002-8564-1709) Shuying Chen (ORCID: https://orcid.org/0009-0000-8596-0630) Biying Wu Institutions Fudan University (CN) Shanghai University of Traditional Chinese Medicine (CN) Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN) Huashan Hospital (CN) Publication Details Journal Frontiers in Oncology Published 2025-04-14 DOI https://doi.org/10.3389/fonc.2025.1577221 Citations 3 Primary Topic Cancer-related molecular mechanisms research Type article Field-Weighted Citation Impact 2.81 Explore the Global Research Space Interactive Map